GGrantIndex
← Search

PHASE I/II, OPEN-LABEL, PHARMACOKINETIC AND SAFETY STUDY OF A NOVEL PROTEASEO

$19,362M01FY2005RRNIH

University Of Southern California, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →